Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/18/2025

COVID-19 Symptom Management

General Management Approach

  • The British Medical Journal recommends putting treatment escalation plans in place for COVID-19 patients as they may deteriorate rapidly and require urgent hospital admission 2, 3
  • The British Medical Journal suggests discussing risks, benefits, and likely outcomes of treatment options with patients and their families to allow them to express preferences about treatment and escalation plans 4
  • For patients with pre-existing advanced comorbidities, the British Medical Journal recommends identifying if they have advance care plans or advance decisions to refuse treatment, including do not attempt resuscitation decisions 4

Managing Specific Symptoms

  • The British Medical Journal recommends encouraging patients with cough to avoid lying on their back as this makes coughing ineffective, and to use simple measures first, including honey for patients aged over 1 year 1, 2
  • The British Medical Journal suggests using short-term codeine linctus, codeine phosphate tablets, or morphine sulfate oral solution for distressing cough 1, 5
  • The British Medical Journal advises patients to drink fluids regularly to avoid dehydration, with a maximum of 2 liters per day, and to recommend paracetamol for fever and other symptoms that antipyretics would help treat, continuing only while symptoms persist 1, 2, 4, 5
  • The British Medical Journal recommends implementing controlled breathing techniques, including proper positioning, pursed-lip breathing, and relaxing and dropping shoulders to reduce hunched posture from anxiety, for breathlessness management 1, 5
  • For end-of-life patients with moderate to severe breathlessness, the British Medical Journal suggests using morphine sulfate immediate-release or modified-release, with concomitant use of an antiemetic and a regular stimulant laxative 1, 4, 5

Pharmacological Interventions

  • The British Medical Journal indicates that remdesivir is recommended for treatment of COVID-19 in adults and pediatric patients who are hospitalized, or not hospitalized with mild-to-moderate COVID-19 but at high risk for progression to severe disease 7

Special Considerations

  • The British Medical Journal notes that patients with comorbidities, frailty, impaired immunity, or reduced ability to cough are at higher risk for developing severe pneumonia 1, 2
  • For immunocompromised patients or those with autoimmune liver disease, the Clinical and Molecular Hepatology journal recommends considering maintaining immunosuppressants rather than discontinuing them, and dose reduction of certain immunosuppressants may be considered if pneumonia worsens with lymphopenia and persisting fever 6

Non-Pharmacological Interventions

  • The International Journal of Surgery recommends implementing social distancing measures to reduce transmission, and delaying non-emergency procedures for COVID-19 patients 6, 8
  • The Clinical and Molecular Hepatology journal suggests ensuring healthcare workers comply with standard precautionary guidelines during all medical procedures 6

Self-Management Support

  • The British Medical Journal recommends providing advice on self-management strategies, including setting realistic goals, and directing patients to reliable sources of information and support groups 7, 9

Follow-up and Monitoring

  • The British Medical Journal suggests agreeing with patients how often follow-up and monitoring are needed, and monitoring for symptom changes, including new or worsening symptoms, with consideration of both in-person and remote monitoring options 7

Common Pitfalls to Avoid

  • The International Journal of Surgery recommends avoiding routine administration of corticosteroids for viral pneumonia unless indicated for another condition or in a clinical trial, and avoiding rapid reduction or discontinuation of immunosuppressants in patients with autoimmune liver disease 6, 8
  • The British Medical Journal suggests avoiding delay in treatment escalation for patients showing signs of deterioration, and avoiding use of opioid patches in opioid-naive patients due to the time needed to reach steady state and high morphine equivalence 1, 2, 3